ENDV:US
$0.00
-33.333%
Endonovo Therapeutics IncNews & Events
Last updated: Jun 9, 2025, 9:25 PM ET
SeeThruEquity Initiates Coverage on Endonovo Therapeutics, Inc. (OTCQB: ENDV) with a Price Target Price of $1.15
ACCESS Newswire MAY 25, 2016 9:01 AM EDTNEW YORK, NY / ACCESSWIRE / May 25, 2016 / SeeThruEquity, a leading independent equity resea...READ ARTICLEHidden Market Patterns, History Repeats Itself - Analyst Notes on Viropro, Baristas Coffee Company, Endonovo Therapeutics and Bayerische Motoren Werke
ACCESS Newswire MAR 14, 2016 7:55 AM EDTNEW YORK, NY / ACCESSWIRE / March 14, 2016 / Moments ago, Trader's Choice released new resea...READ ARTICLEAnalyzing the Price Movement - Analyst Research on StrikeForce Technologies, Greenshift, Progressive Care, and Endonovo Therapeutics
ACCESS Newswire FEB 2, 2016 8:00 AM ESTNEW YORK, NY / ACCESSWIRE / February 2, 2016 / Moments ago, Trader's Choice released new res...READ ARTICLE